RESEARCH & DEVELOPMENT (TABLES)

9 Months Ended

Sep. 30, 2012

Notes To Consolidated Financial Statement [Abstract]

Research And Development Expense Detail Table [Text Block]

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2012		2011		2012		2011
Ongoing research and development costs	$	11,833	$	7,638	$	39,337	$	21,588
Payments related to strategic collaborations		(500)		21,000		46,506		35,500
Share-based compensation expense		930		95		1,563		1,114
Total research and development	$	12,263	$	28,733	$	87,406	$	58,202